The Global Healthcare Private Equity and M&A Report 2022 explores how investors navigated a period of major disruption marked by market volatility, regulatory shifts, and continued effects of the pandemic. Despite uncertainty, healthcare remained attractive due to strong long‑term demand and innovation opportunities. Winning investors adapted by focusing on resilience, selective dealmaking, and operational value creation rather than pursuing scale alone. M&A activity emphasized add‑on acquisitions, platform building, and innovation‑driven assets, while private equity firms doubled down on improving portfolio company performance. The report highlights that success during discontinuity depends on strategic agility, deep sector expertise, and the ability to promote innovation while managing r

Join for free to read